Review of drugs: call for evidence
Published 10 May 2019
© Crown copyright 2019
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/review-of-drugs-call-for-evidence/review-of-drugs-call-for-evidence
This call for evidence forms part of the information gathering phase of the review, encouraging interested parties to share their insights and experiences in order to increase our understanding of both drug use and drug supply.
About this call for evidence
The responses to this call for evidence will be used, in conjunction with other sources such as official statistics, visits, research reports and academic literature, to build a detailed, up-to-date picture of drug use and supply, and to assess the effectiveness of interventions.
Responses will be read carefully and assessed in terms of the strength and quality of evidence they contain.
Respondents are therefore encouraged to provide the detail of sources and references wherever relevant.
Responses relating to part 1 of the review will be assessed first. Responses of greater relevance to part 2 (for example, the effectiveness of treatment and recovery) may be assessed at a later stage once the second part of the review is under way.
Only evidence which falls within the scope of the review will be considered. In particular, changes to the legislative framework are out of scope.
How to respond
Respondents should feel free to answer as many or as few questions as they wish to. They should not feel they have to comment on every area but to focus on where they have a strong evidence base for their response. When responding to a particular question, please:
- give specifics (for example, the drug or drugs being referred to, over what time period, in which geographic areas, among which groups of people, as relevant)
- reference any sources of data and provide evidence where possible
- keep responses as concise as possible.
Responses to this call for evidence should be submitted online.
Deadline for responses
The closing date for submissions is 11:59pm on 7 June 2019
If you’re unable to submit your answers online, for example because you use specialist accessibility software that is not compatible with the system, please contact us at independentreviewofdrugs@homeoffice.gov.uk and we will work with you to find a different way of responding.
Confidentiality
Information you give in response to consultations may be subject to publication or disclosure under the Freedom of Information Act 2000 or the Environmental Information Regulations 2004.
The review will only process any personal data it receives as part of this consultation (for example, any identifying material) according to data protection law. This means your personal data will only be used for the purpose of the call for evidence. It will not be disclosed to third parties unless the law requires it, and you will not be identifiable from any published reports.
If you want all, or any part, of a response to be treated as confidential, please explain why you consider it to be confidential.
If we receive a request for disclosure of the information you have given, we will take into account your explanation about why you consider it to be confidential. However, we can’t guarantee confidentiality.